Please ensure Javascript is enabled for purposes of website accessibility

7 IPOs That Dared to Go Public in 2013

By Rick Munarriz – Jan 28, 2013 at 8:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These seven companies became Wall Street debutantes this month.

After a month-long holiday lull, the IPO pipeline began gushing again two weeks ago. Despite many prolific new offerings that crashed in 2012, the market's resilient returns and the investing appetite for new things will keep the debutantes flowing through 2013.

Not many companies have successfully introduced their offerings, so let's take a look at the rookie class so far.





Bright Horizons (BFAM 4.94%)




LipoScience (NASDAQ: LPDX)




CyrusOne (CONE)




Norwegian Cruise Line (NCLH -0.79%)




SunCoke Energy 




CVR Refining 




USA Compression (USAC -1.34%)




Source: The Wall Street Journal.

If you see plenty more IPOs hit the market in the coming weeks, the table on top will explain why this is happening. All but one of this month's seven IPOs is trading below its underwriter offering price.

The lone sinker is intriguing. USA Compression is a master limited partnership structured around the compression of natural gas. The Wall Street Journal earlier this month pointed out that USA Compression was the first limited partnership to fall on its first day of trading in more than a year. The high distributions of MLPs and the healthy interest in natural gas should have helped the offering, but they didn't.

The other stocks have held up far better, but let's take a closer look at the four companies that have come through with double-digit percentage returns. 

Bright Horizons is a leading day-care services provider. Bain Capital is a majority investor of the debt-saddled company, but don't let the kids hear that. Bright Horizons began trading on Friday.

LipoScience also went public on Friday. Bright Horizons and LipoScience were the only two companies to complete their new offerings last week. LipoScience's proprietary NMR LipoProfile test measures the number of low-density lipoprotein particles in a blood sample. The diagnostic test for gauging heart disease risk has been ordered 8 million times. 

CyrusOne operates two dozen data centers worldwide. Among its 500 customers are 100 of the Fortune 1000 companies. It went public at $19 two weeks ago.

Norwegian Cruise Line -- or NCL -- is probably the most familiar name on the list of 2013 debutantes. The cruise line has been trying to go public for more than two years, and now joins its two cruising rivals as publicly traded entities. Cruise ships offer interesting plays on global tourism along with the tax-friendly benefits of generating a lot of their revenue on the high seas.

Longtime Fool contributor Rick Aristotle Munarriz has no position in any stocks mentioned, and neither does The Motley Fool. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Norwegian Cruise Line Holdings Stock Quote
Norwegian Cruise Line Holdings
$16.44 (-0.79%) $0.13
CyrusOne Stock Quote
USA Compression Partners Common Units Stock Quote
USA Compression Partners Common Units
$18.37 (-1.34%) $0.25
Bright Horizons Family Solutions Stock Quote
Bright Horizons Family Solutions
$74.20 (4.94%) $3.49

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.